Hodgkin Lymphoma Global Clinical Trials Review, H2, 2015

Date: August 19, 2015
Pages: 142
Price:
US$ 2,500.00 US$ 2,000.00
Offer valid until December 31, 2016!
License [?]:
Publisher: GlobalData
Report type: Strategic Report
Delivery: E-mail Delivery (PDF)
ID: HAB72CCCE7AEN
Leaflet:

Download PDF Leaflet

Hodgkin Lymphoma Global Clinical Trials Review, H2, 2015

SUMMARY

GlobalData's clinical trial report, “Hodgkin Lymphoma Global Clinical Trials Review, H2, 2015' provides an overview of Hodgkin Lymphoma clinical trials scenario. This report provides top line data relating to the clinical trials on Hodgkin Lymphoma. Report includes an overview of trial numbers and their average enrollment in top countries conducted across the globe. The report offers coverage of disease clinical trials by region, country (G7 & E7), phase, trial status, end points status and sponsor type. Report also provides prominent drugs for in-progress trials (based on number of ongoing trials). Global Data Clinical Trial Reports are generated using Global Data’s proprietary database - Pharma eTrack Clinical trials database. Clinical trials are collated from 80+ different clinical trial registries, conferences, journals, news etc across the globe. Clinical trials database undergoes periodic update by dynamic process.

The report enhances the decision making capabilities and helps to create an effective counter strategies to gain competitive advantage.

Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

SCOPE
  • The report provides a snapshot of the global clinical trials landscape
  • Report provides top level data related to the clinical trials by Region, Country (G7 & E7), Trial Status, Trial Phase, Sponsor Type and End point status
  • The report reviews top companies involved and enlists all trials (Trial title, Phase, and Status) pertaining to the company
  • The report provides all the unaccomplished trials (Terminated, Suspended and Withdrawn) with reason for unaccomplishment
  • The Report provides enrollment trends for the past five years
  • Report provides latest news for the past three months
Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

REASONS TO BUY
  • Assists in formulating key business strategies with regards to investment
  • Helps in identifying prominent locations for conducting clinical trials which saves time and cost
  • Provides top level analysis of Global Clinical Trials Market which helps in identifying key business opportunities
  • Supports understanding of trials count and enrollment trends by country in global therapeutics market
  • Aids in interpreting the success rates of clinical trials by providing a comparative scenario of completed and uncompleted (terminated, suspended or withdrawn) trials
  • Facilitates clinical trial assessment of the indication on a global, regional and country level
Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.
Introduction
Hodgkin Lymphoma
Report Guidance
Clinical Trials by Region
Clinical Trials and Average Enrollment by Country
Top Five Countries Contributing to Clinical Trials in Asia-Pacific
Top Five Countries Contributing to Clinical Trials in Europe
Top Countries Contributing to Clinical Trials in North America
Top Countries Contributing to Clinical Trials in Middle East and Africa
Top Countries Contributing to Clinical Trials in Central and South America
Clinical Trials by G7 Countries: Proportion of Hodgkin Lymphoma to Oncology Clinical Trials
Clinical Trials by Phase in G7 Countries
Clinical Trials in G7 Countries by Trial Status
Clinical Trials by E7 Countries: Proportion of Hodgkin Lymphoma to Oncology Clinical Trials
Clinical Trials by Phase in E7 Countries
Clinical Trials in E7 Countries by Trial Status
Clinical Trials by Phase
In Progress Trials by Phase
Clinical Trials by Trial Status
Clinical Trials by End Point Status
Unaccomplished Trials of Hodgkin Lymphoma
Subjects Recruited Over a Period of Time
Clinical Trials by Sponsor Type
Prominent Sponsors
Top Companies Participating in Hodgkin Lymphoma Therapeutics Clinical Trials
Prominent Drugs
Latest Clinical Trials News on Hodgkin Lymphoma
Jun 17, 2015: Seattle Genetics Announces Multiple ADCETRIS (Brentuximab Vedotin) Data Presentations at the International Conference on Malignant Lymphoma
May 31, 2015: Curis Reports CUDC-907 Data From the Ongoing Phase 1 Trial at the 2015 ASCO Annual Meeting
May 29, 2015: Cellular Biomedicine Group to Provide Business and Clinical Updates at Jefferies 2015 Global Healthcare Conference
May 22, 2015: Positive Phase I Results From CAR-T CD30 Immuno-Oncology Clinical Development Program
Clinical Trial Profiles
Clinical Trial Overview of Top Companies
Seattle Genetics, Inc.
Clinical Trial Overview of Seattle Genetics, Inc.
Takeda Pharmaceutical Company Limited
Clinical Trial Overview of Takeda Pharmaceutical Company Limited
Novartis AG
Clinical Trial Overview of Novartis AG
Celgene Corporation
Clinical Trial Overview of Celgene Corporation
Bristol-Myers Squibb Company
Clinical Trial Overview of Bristol-Myers Squibb Company
Sanofi
Clinical Trial Overview of Sanofi
Merck & Co., Inc.
Clinical Trial Overview of Merck & Co., Inc.
F. Hoffmann-La Roche Ltd.
Clinical Trial Overview of F. Hoffmann-La Roche Ltd.
Amgen Inc.
Clinical Trial Overview of Amgen Inc.
AbbVie Inc.
Clinical Trial Overview of AbbVie Inc.
Clinical Trial Overview of Top Institutes / Government
National Cancer Institute
Clinical Trial Overview of National Cancer Institute
Fred Hutchinson Cancer Research Center
Clinical Trial Overview of Fred Hutchinson Cancer Research Center
The University of Texas M. D. Anderson Cancer Center
Clinical Trial Overview of The University of Texas M. D. Anderson Cancer Center
Memorial Sloan Kettering Cancer Center
Clinical Trial Overview of Memorial Sloan Kettering Cancer Center
Baylor College of Medicine
Clinical Trial Overview of Baylor College of Medicine
University of Cologne
Clinical Trial Overview of University of Cologne
Children's Oncology Group
Clinical Trial Overview of Children's Oncology Group
Stanford University
Clinical Trial Overview of Stanford University
Case Comprehensive Cancer Center
Clinical Trial Overview of Case Comprehensive Cancer Center
Massachusetts General Hospital
Clinical Trial Overview of Massachusetts General Hospital
Five Key Clinical Profiles
Appendix
Abbreviations
Definitions
Research Methodology
Secondary Research
About GlobalData
Contact Us
Disclaimer
Source

LIST OF TABLES

Hodgkin Lymphoma Therapeutics, Global, Clinical Trials by Region, 2015
Hodgkin Lymphoma Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2015
Hodgkin Lymphoma Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2015
Hodgkin Lymphoma Therapeutics Clinical Trials, Asia-Pacific, Top Five Countries, 2015
Hodgkin Lymphoma Therapeutics Clinical Trials, Europe, Top Five Countries, 2015
Hodgkin Lymphoma Therapeutics Clinical Trials, North America, Top Countries, 2015
Hodgkin Lymphoma Therapeutics Clinical Trials, Middle East and Africa, Top Countries, 2015
Hodgkin Lymphoma Therapeutics Clinical Trials, Central and South America, Top Countries, 2015
Proportion of Hodgkin Lymphoma to Oncology Clinical Trials, G7 Countries (%), 2015
Hodgkin Lymphoma Therapeutics, G7 Countries, Clinical Trials by Phase, 2015
Hodgkin Lymphoma Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2015
Proportion of Hodgkin Lymphoma to Oncology Clinical Trials, E7 Countries (%), 2015
Hodgkin Lymphoma Therapeutics, E7 Countries, Clinical Trials by Phase, 2015
Hodgkin Lymphoma Therapeutics, E7 Countries, Clinical Trials by Trial Status, 2015
Hodgkin Lymphoma Therapeutics, Global, Clinical Trials by Phase, 2015
Hodgkin Lymphoma Therapeutics, Global, Clinical Trials In Progress by Phase 2015
Hodgkin Lymphoma Therapeutics, Global, Clinical Trials by Trial Status, 2015
Hodgkin Lymphoma Therapeutics Clinical Trials, Global, by End Point Status, 2015
Hodgkin Lymphoma Therapeutics, Global, Suspended Clinical Trials, 2015
Hodgkin Lymphoma Therapeutics, Global, Withdrawn Clinical Trials, 2015
Hodgkin Lymphoma Therapeutics, Global, Terminated Clinical Trials, 2015
Hodgkin Lymphoma Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2010-2014
Hodgkin Lymphoma Therapeutics Market, Global, Clinical Trials by Sponsor Type, 2015
Hodgkin Lymphoma Therapeutics Clinical Trials, Global, Key Sponsors, 2015
Hodgkin Lymphoma Therapeutics Clinical Trials, Global, Top Companies by Phase, 2015
Hodgkin Lymphoma Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2015
Hodgkin Lymphoma Therapeutics Clinical Trials Market, Global, Clinical Trials by Seattle Genetics, Inc., 2015
Hodgkin Lymphoma Therapeutics Clinical Trials Market, Global, Clinical Trials by Takeda Pharmaceutical Company Limited, 2015
Hodgkin Lymphoma Therapeutics Clinical Trials Market, Global, Clinical Trials by Novartis AG, 2015
Hodgkin Lymphoma Therapeutics Clinical Trials Market, Global, Clinical Trials by Celgene Corporation, 2015
Hodgkin Lymphoma Therapeutics Clinical Trials Market, Global, Clinical Trials by Bristol-Myers Squibb Company, 2015
Hodgkin Lymphoma Therapeutics Clinical Trials Market, Global, Clinical Trials by Sanofi, 2015
Hodgkin Lymphoma Therapeutics Clinical Trials Market, Global, Clinical Trials by Merck & Co., Inc., 2015
Hodgkin Lymphoma Therapeutics Clinical Trials Market, Global, Clinical Trials by F. Hoffmann-La Roche Ltd., 2015
Hodgkin Lymphoma Therapeutics Clinical Trials Market, Global, Clinical Trials by Amgen Inc., 2015
Hodgkin Lymphoma Therapeutics Clinical Trials Market, Global, Clinical Trials by AbbVie Inc., 2015
Hodgkin Lymphoma Therapeutics Clinical Trials Market, Global, Clinical Trials by National Cancer Institute, 2015
Hodgkin Lymphoma Therapeutics Clinical Trials Market, Global, Clinical Trials by Fred Hutchinson Cancer Research Center, 2015
Hodgkin Lymphoma Therapeutics Clinical Trials Market, Global, Clinical Trials by The University of Texas M. D. Anderson Cancer Center, 2015
Hodgkin Lymphoma Therapeutics Clinical Trials Market, Global, Clinical Trials by Memorial Sloan Kettering Cancer Center, 2015
Hodgkin Lymphoma Therapeutics Clinical Trials Market, Global, Clinical Trials by Baylor College of Medicine, 2015
Hodgkin Lymphoma Therapeutics Clinical Trials Market, Global, Clinical Trials by University of Cologne, 2015
Hodgkin Lymphoma Therapeutics Clinical Trials Market, Global, Clinical Trials by Children's Oncology Group, 2015
Hodgkin Lymphoma Therapeutics Clinical Trials Market, Global, Clinical Trials by Stanford University, 2015
Hodgkin Lymphoma Therapeutics Clinical Trials Market, Global, Clinical Trials by Case Comprehensive Cancer Center, 2015
Hodgkin Lymphoma Therapeutics Clinical Trials Market, Global, Clinical Trials by Massachusetts General Hospital, 2015

LIST OF FIGURES

Hodgkin Lymphoma Therapeutics, Global, Clinical Trials by Region (%), 2015
Hodgkin Lymphoma Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2015
Hodgkin Lymphoma Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2015
Hodgkin Lymphoma Therapeutics Clinical Trials, Asia-Pacific, Top Five Countries (%), 2015
Hodgkin Lymphoma Therapeutics Clinical Trials, Europe, Top Five Countries (%), 2015
Hodgkin Lymphoma Therapeutics Clinical Trials, North America, Top Countries (%), 2015
Hodgkin Lymphoma Therapeutics Clinical Trials, Middle East and Africa, Top Countries (%), 2015
Proportion of Hodgkin Lymphoma to Oncology Clinical Trials, G7 Countries (%), 2015
Hodgkin Lymphoma Therapeutics, G7 Countries, Clinical Trials by Phase, 2015
Hodgkin Lymphoma Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2015
Proportion of Hodgkin Lymphoma to Oncology Clinical Trials, E7 Countries (%), 2015
Hodgkin Lymphoma Therapeutics, E7 Countries, Clinical Trials by Phase, 2015
Hodgkin Lymphoma Therapeutics, E7 Countries, Clinical Trials by Trial Status, 2015
Hodgkin Lymphoma Therapeutics, Global, Clinical Trials by Phase (%), 2015
Hodgkin Lymphoma Therapeutics, Global, Clinical Trials In Progress by Phase, 2015
Hodgkin Lymphoma Therapeutics, Global, Clinical Trials by Trial Status, 2015
Hodgkin Lymphoma Therapeutics Clinical Trials, Global, by End Point Status, 2015
Hodgkin Lymphoma Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2010-2014
Hodgkin Lymphoma Therapeutics Market, Global, Clinical Trials by Sponsor Type (%), 2015
Hodgkin Lymphoma Therapeutics Clinical Trials, Global, Key Sponsors, 2015
Hodgkin Lymphoma Therapeutics Clinical Trials, Global, Top Companies by Phase, 2015
Hodgkin Lymphoma Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2015
GlobalData Methodology

COMPANIES MENTIONED

Seattle Genetics, Inc.
Takeda Pharmaceutical Company Limited
Novartis AG
Celgene Corporation
Bristol-Myers Squibb Company
Sanofi
Merck & Co., Inc.
F. Hoffmann-La Roche Ltd.
Amgen Inc.
AbbVie Inc.
Skip to top


Ask Your Question

Hodgkin Lymphoma Global Clinical Trials Review, H2, 2015
Company name*:
Contact person*:
Phone/fax*:
Email*:
Request invoice
Your enquiry:
Please click on a Check Box below to confirm you are not a robot: